These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2431829)

  • 1. Tests on protection against viral diseases.
    Büttner M; Mayr A
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):205-15. PubMed ID: 2431829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of non-specific antiviral defence mechanisms in NMRI-mice by cell culture mediators.
    Reubel G; Büttner M; Mayr A
    Zentralbl Veterinarmed B; 1986 Oct; 33(8):557-67. PubMed ID: 2432743
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effect of viral paramunity inducers PIND-AVI and PIND-ORF with that of BCG, Corynebacterium parvum and levamisole on the growth of radiation-induced murine osteosarcoma.
    Müller-Brunecker G; Erfle V; Mayr A
    Zentralbl Veterinarmed B; 1986 Apr; 33(3):188-95. PubMed ID: 3463079
    [No Abstract]   [Full Text] [Related]  

  • 5. Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways.
    Boudinot P; Riffault S; Salhi S; Carrat C; Sedlik C; Mahmoudi N; Charley B; Benmansour A
    J Gen Virol; 2000 Nov; 81(Pt 11):2675-2682. PubMed ID: 11038379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulators as antiviral agents.
    Steele RW; Charlton RK
    Clin Lab Med; 1987 Dec; 7(4):911-24. PubMed ID: 2446821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of interferon in rats and the effect of immune suppression.
    Schellekens H; Smiers-de Vreede E; de Reus A; Dijkema R
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():391-6. PubMed ID: 6198453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of the immunostimulating (paramunizing) effectiveness of BCG, levamisole, Corynebacterium parvum and preparations of pock viruses in various in vivo and in vitro tests].
    Mayr A; Büttner M; Pawlas S; Erfle V; Mayr B; Brunner R; Osterkorn K
    Zentralbl Veterinarmed B; 1986 Jun; 33(5):321-39. PubMed ID: 2430381
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic response modifiers as antivirals in immunosuppressed hosts.
    Morahan PS; Pinto AJ
    Adv Exp Med Biol; 1992; 319():243-51. PubMed ID: 1384281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(1):45-57. PubMed ID: 3035349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
    van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific enhancers of resistance in man.
    Florman AL; Holzman RS
    J Pediatr; 1975 Dec; 87(6 Pt 2):1094-1102. PubMed ID: 1102645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine.
    Zuckermann FA; Husmann RJ; Schwartz R; Brandt J; Mateu de Antonio E; Martin S
    Vet Immunol Immunopathol; 1998 May; 63(1-2):57-67. PubMed ID: 9656441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental vesicular stomatitis virus infection of swine: extent of infection and immunological response.
    Redelman D; Nichol S; Klieforth R; Van Der Maaten M; Whetstone C
    Vet Immunol Immunopathol; 1989 Mar; 20(4):345-61. PubMed ID: 2470190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of protection of mice against herpes simplex virus type 2 infection by Propionibacterium.
    Ohashi M; Amagai T; Ushijima T; Imanishi J; Kishida T; Ozaki Y
    Microbiol Immunol; 1983; 27(7):601-9. PubMed ID: 6195512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological response modifiers in the management of viral infection.
    Ford RB
    Vet Clin North Am Small Anim Pract; 1986 Nov; 16(6):1191-204. PubMed ID: 3538633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of virus infections by natural killer cells. A review.
    Welsh RM
    Nat Immun Cell Growth Regul; 1986; 5(4):169-99. PubMed ID: 2430177
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
    Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
    Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.